Massachusetts Lawmakers Prioritize Health Policy
Katherine O'Malley
August 12, 2026
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
Because they may reduce traditional Medicare (TM) spending, Medicare Advantage (MA) plans may not be, on net, as costly as we think. In my latest AcademyHealth
Although it’s been eclipsed by the presidential election, the fight over the risk corridor lawsuits continues to simmer. Last Friday, the House of Representatives moved
The following originally appeared on The Upshot (copyright 2016, The New York Times Company). It also appeared on page A3 of the 10 October 2016 print edition.
As we pass the 3-year anniversary of the opening of the insurance exchanges, most news seems to focus on the private insurance people can purchase
In JAMA Internal Medicine, David Levine, Jeffrey Linder, and Bruce Landon look at progress in improving quality of care in the US since 2002. They are not
Insurers pay more for multiple sclerosis drug because rebates don’t help, report says, STAT Drug Coupons: Helping a Few at the Expense of Everyone, NYT
6 Things That Happened in Health Policy This Week is produced by a mix of research assistants from the Healthcare Quality & Outcomes (HQO) Initiative
The following originally appeared on The Upshot (copyright 2016, The New York Times Company). You may have read or heard about the study debunking the five-second rule.
For decades, public health experts have known that syringe exchange programs reduce the spread of certain viral infections — like H.I.V.,hepatitis B and hepatitis C
I just have too much on my plate these days. I meant to get to this earlier, but better later than never. “Population-Based Incidence Rates
Pointing out that there could be an innovation–access tradeoff is often too simplistic, however. Some policy proposals on drug pricing that would broaden access might also stifle innovation,